Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions
- PMID: 19398216
- DOI: 10.1016/j.jcv.2009.03.019
Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions
Abstract
Background: The association between human papillomavirus (HPV) viral load and high-grade squamous intraepithelial lesion (HSIL) of the uterine cervix has been demonstrated for high-risk HPV-16 but has not been investigated for low-risk HPV types.
Objective: To determine the association between the presence of low-grade SIL (LSIL) and viral load of low-risk HPV type 6.
Study design: 107 HPV-6-positive cytobrush samples collected from 90 women (67 without SIL, 11 with LSIL, 5 with HSIL, 6 with SIL of unknown grade and 1 with a smear with LSIL and a normal colposcopy) were analyzed for their content of HPV-6 DNA.
Methods: HPV-6 E6 and E2 DNA loads were measured in the cytobrush samples with two real-time PCR assays. HPV-6 integration was confirmed with restriction-site PCR.
Results: HPV-6 DNA in cervical samples ranged from 1.8 x 10(2) to 4.25 x 10(8) copies per microg of cellular DNA. HPV-6 E6 DNA loads were higher in women with LSIL, with or without co-infection with high-risk HPV types, than in women without SIL (p=0.03). HPV-6 loads greater than 8.76 x 10(6)copies per microgDNA, corresponding to the mean HPV-6 load measured in women with LSIL, were more frequently detected in these women with LSIL than in women without LSIL, controlling for age (odds ratio 13.5, 95% confidence interval 1.1-172.4). Although 10 samples generated HPV-6 E6/E2 ratios above 2, there was no evidence of integration of HPV-6 by restriction-site PCR.
Conclusion: Samples from women with LSIL contained higher HPV-6 loads than women without SIL. HPV-6 DNA was not integrated into cellular DNA in these samples.
Similar articles
-
Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.Cancer. 2002 Apr 15;94(8):2199-210. doi: 10.1002/cncr.10439. Cancer. 2002. PMID: 12001118
-
Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.Int J Cancer. 2007 Dec 15;121(12):2674-81. doi: 10.1002/ijc.23006. Int J Cancer. 2007. PMID: 17708553
-
[Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions].Zhonghua Yi Xue Za Zhi. 2011 Apr 5;91(13):906-10. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21600119 Chinese.
-
The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.J Low Genit Tract Dis. 2009 Apr;13(2):72-8. doi: 10.1097/LGT.0b013e318183bb0e. J Low Genit Tract Dis. 2009. PMID: 19387126 Review.
-
A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination.Vaccine. 2008 Jun 2;26(23):2811-7. doi: 10.1016/j.vaccine.2008.03.047. Epub 2008 Apr 11. Vaccine. 2008. PMID: 18450340 Review.
Cited by
-
The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions.J Cytol. 2013 Jan;30(1):1-7. doi: 10.4103/0970-9371.107504. J Cytol. 2013. PMID: 23661932 Free PMC article.
-
High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis.Papillomavirus Res. 2019 Dec;8:100181. doi: 10.1016/j.pvr.2019.100181. Epub 2019 Aug 22. Papillomavirus Res. 2019. PMID: 31446060 Free PMC article.